Endoglin is a novel endothelial cell specification gene

Stem Cell Research

Volumn 8, Issue 1, 2012, Pages 85-96

  Banerjee, Saswati ^a   Dhara, Sujoy K ^b   Bacanamwo, Methode ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; BONE MORPHOGENETIC PROTEIN 4; CD31 ANTIGEN; ENDOGLIN; INTERCELLULAR ADHESION MOLECULE 1; RECOMBINANT PROTEIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; SONIC HEDGEHOG PROTEIN; VASCULAR ENDOTHELIAL CADHERIN; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL JUNCTION; CELL POPULATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; FLOW CYTOMETRY; IMMUNOCYTOCHEMISTRY; MESODERM; MOLECULAR MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL MARKERS; BONE MORPHOGENETIC PROTEIN 4; CELL COUNT; CELL DIFFERENTIATION; CELL LINE; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; FETAL PROTEINS; HEDGEHOG PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MESODERM; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; ORGAN SPECIFICITY; PHOSPHORYLATION; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SMAD PROTEINS; T-BOX DOMAIN PROTEINS;

ERINACEIDAE;

EID: 80053365788     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2011.08.006     Document Type: Article

References (36)

1. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
2. Bai H., Chen K., Arzigian M., Wang Z. Sequential roles of BMP-4, VEGF and FGF-2 in generation of CD34+ vascular progenitor cells from human embryonic stem cells under animal product-free condition. Cell Res. 2008, 18:s108.
3. Banerjee S., Bacanamwo M. DNA methyltransferase inhibition induces mouse embryonic stem cell differentiation into endothelial cells. Exp. Cell Res. 2010, 316:172-180.
4. Boyd N.L., Dhara S.K., Rekaya R., Godbey E.A., Hasneen K., Rao R.R., West F.D., Gerwe B.A., Stice S.L. BMP4 promotes formation of primitive vascular networks in human embryonic stem cell-derived embryoid bodies. Exp. Biol. Med. (Maywood) 2007, 232:833-843.
5. Cheifetz S., Bellon T., Cales C., Vera S., Bernabeu C., Massague J., Letarte M. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J. Biol. Chem. 1992, 267:19027-19030.
6. Elzarrad K., Haroon A., Reed D., Al-Mehdi A.B. Early incorporated endothelial cells as origin of metastatic tumor vasculogenesis. Clin. Exp. Metastasis 2009, 26:589-598.
7. Iacobas I., Vats A., Hirschi K.K. Vascular potential of human pluripotent stem cells. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1110-1117.
8. Kelly M.A., Hirschi K.K. Signaling hierarchy regulating human endothelial cell development. Arterioscler. Thromb. Vasc. Biol. 2009, 29:718-724.
9. Kim J., Kim J.Y., Song K.S., Lee Y.H., Seo J.S., Jelinek J., Goldschmidt-Clermont P.J., Issa J.P. Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence. Biochim. Biophys. Acta 2007, 1772:72-80.
10. Kisanuki Y.Y., Hammer R.E., Miyazaki J., Williams S.C., Richardson J.A., Yanagisawa M. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev. Biol. 2001, 230:230-242.
11. Kispert A., Herrmann B.G. Immunohistochemical analysis of the Brachyury protein in wild-type and mutant mouse embryos. Dev. Biol. 1994, 161:179-193.
12. Landmesser U., Hornig B., Drexler H. Endothelial function: a critical determinant in atherosclerosis?. Circulation 2004, 109:II27-II33.
13. Lebrin F., Mummery C.L. Endoglin-mediated vascular remodeling: mechanisms underlying hereditary hemorrhagic telangiectasia. Trends Cardiovasc. Med. 2008, 18:25-32.
14. Lebrin F., Goumans M.J., Jonker L., Carvalho R.L., Valdimarsdottir G., Thorikay M., Mummery C., Arthur H.M., ten Dijke P. Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. EMBO J. 2004, 23:4018-4028.
15. Levenberg S., Zoldan J., Basevitch Y., Langer R. Endothelial potential of human embryonic stem cells. Blood 2007, 110:806-814.
16. Levine R.J., Lam C., Qian C., Yu K.F., Maynard S.E., Sachs B.P., Sibai B.M., Epstein F.H., Romero R., Thadhani R., Karumanchi S.A. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N. Engl. J. Med. 2006, 355:992-1005.
17. Liu P., Wakamiya M., Shea M.J., Albrecht U., Behringer R.R., Bradley A. Requirement for Wnt3 in vertebrate axis formation. Nat. Genet. 1999, 22:361-365.
18. Liu C., Wang S., Deb A., Nath K.A., Katusic Z.S., McConnell J.P., Caplice N.M. Proapoptotic, antimigratory, antiproliferative, and antiangiogenic effects of commercial C-reactive protein on various human endothelial cell types in vitro: implications of contaminating presence of sodium azide in commercial preparation. Circ. Res. 2005, 97:135-143.
19. Liu C., Wang S., Metharom P., Caplice N.M. Myeloid lineage of human endothelial outgrowth cells circulating in blood and vasculogenic endothelial-like cells in the diseased vessel wall. J. Vasc. Res. 2009, 46:581-591.
20. Mahpatra S., Firpo M.T., Bacanamwo M. Inhibition of DNA methyltransferases and histone deacetylases induces bone marrow-derived multipotent adult progenitor cells to differentiate into endothelial cells. Ethn. Dis. 2010, 20:60-64. S1.
21. Maitra A., Arking D.E., Shivapurkar N., Ikeda M., Stastny V., Kassauei K., Sui G., Cutler D.J., Liu Y., Brimble S.N., Noaksson K., Hyllner J., Schulz T.C., Zeng X., Freed W.J., Crook J., Abraham S., Colman A., Sartipy P., Matsui S., Carpenter M., Gazdar A.F., Rao M., Chakravarti A. Genomic alterations in cultured human embryonic stem cells. Nat. Genet. 2005, 37:1099-1103.
22. McCloskey K.E., Smith D.A., Jo H., Nerem R.M. Embryonic stem cell-derived endothelial cells may lack complete functional maturation in vitro. J. Vasc. Res. 2006, 43:411-421.
23. Nakayama N., Lee J., Chiu L. Vascular endothelial growth factor synergistically enhances bone morphogenetic protein-4-dependent lymphohematopoietic cell generation from embryonic stem cells in vitro. Blood 2000, 95:2275-2283.
24. Nikolova-Krstevski V., Yuan L., Le Bras A., Vijayaraj P., Kondo M., Gebauer I., Bhasin M., Carman C.V., Oettgen P. ERG is required for the differentiation of embryonic stem cells along the endothelial lineage. BMC Dev. Biol. 2009, 9:72.
25. Nourse M.B., Halpin D.E., Scatena M., Mortisen D.J., Tulloch N.L., Hauch K.D., Torok-Storb B., Ratner B.D., Pabon L., Murry C.E. VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arterioscler. Thromb. Vasc. Biol. 2010, 30:80-89.
26. Pearson S., Sroczynska P., Lacaud G., Kouskoff V. The stepwise specification of embryonic stem cells to hematopoietic fate is driven by sequential exposure to Bmp4, activin A, bFGF and VEGF. Development 2008, 135:1525-1535.
27. Poole T.J., Finkelstein E.B., Cox C.M. The role of FGF and VEGF in angioblast induction and migration during vascular development. Dev. Dyn. 2001, 220:1-17.
28. ten Dijke P., Arthur H.M. Extracellular control of TGFbeta signalling in vascular development and disease. Nat. Rev. Mol. Cell Biol. 2007, 8:857-869.
29. ten Dijke P., Goumans M.J., Pardali E. Endoglin in angiogenesis and vascular diseases. Angiogenesis 2008, 11:79-89.
30. Tokuda H., Hatakeyama D., Shibata T., Akamatsu S., Oiso Y., Kozawa O. p38 MAP kinase regulates BMP-4-stimulated VEGF synthesis via p70 S6 kinase in osteoblasts. Am. J. Physiol. Endocrinol. Metab. 2003, 284:E1202-E1209.
31. van Laake L.W., van den Driesche S., Post S., Feijen A., Jansen M.A., Driessens M.H., Mager J.J., Snijder R.J., Westermann C.J., Doevendans P.A., van Echteld C.J., ten Dijke P., Arthur H.M., Goumans M.J., Lebrin F., Mummery C.L. Endoglin has a crucial role in blood cell-mediated vascular repair. Circulation 2006, 114:2288-2297.
32. Venkatesha S., Toporsian M., Lam C., Hanai J., Mammoto T., Kim Y.M., Bdolah Y., Lim K.H., Yuan H.T., Libermann T.A., Stillman I.E., Roberts D., D'Amore P.A., Epstein F.H., Sellke F.W., Romero R., Sukhatme V.P., Letarte M., Karumanchi S.A. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat. Med. 2006, 12:642-649.
33. Wang J.M., Wilson P.B., Kumar S., Pye D., Hunter R.D. Quantitation of endothelial cell specific protein E-9 employing a single monoclonal antibody in an indirect sandwich ELISA. J. Immunol. Methods 1994, 171:55-64.
34. Willerson J.T., Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 2004, 109:II2-II10.
35. Winnier G., Blessing M., Labosky P.A., Hogan B.L. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 1995, 9:2105-2116.
36. Zhang P., Li J., Tan Z., Wang C., Liu T., Chen L., Yong J., Jiang W., Sun X., Du L., Ding M., Deng H. Short-term BMP-4 treatment initiates mesoderm induction in human embryonic stem cells. Blood 2008, 111:1933-1941.